Photobiomodulation applied before exercise significantly reduces inflammatory markers and accelerates muscle recovery, meta-analysis of 38 randomized controlled trials.
This meta-analysis by Nampo et al. (2022), published in Lasers in Surgery and Medicine, analyzes 38 randomized controlled trials on the use of photobiomodulation (PBM) as a sports recovery tool. It represents one of the most comprehensive syntheses to date on this subject.
The researchers evaluated the impact of PBM on biochemical markers of muscle inflammation, primarily creatine kinase (CK) and interleukin-6 (IL-6), as well as on physical performance measured 24 to 72 hours after exercise.
Results show a robust and consistent effect of pre-exercise PBM on the reduction of inflammation, the limitation of exercise-induced muscle damage and the improvement of performance during repeated efforts.
Systematic meta-analysis including 38 randomized controlled trials (RCTs). Studies were selected according to PRISMA criteria, with rigorous bias risk assessment via the Cochrane RoB 2.0 tool.
Healthy adults practicing structured physical exercise, including amateur athletes, semi-professional athletes and sedentary participants. Total: approximately 1,200 participants spread across the included studies.
Tested wavelengths: 630–904 nm (red and near-infrared). Typical energy dose: 10–50 J per application site. PBM was applied to the muscle groups solicited, 10 to 30 minutes before exercise.
Biochemical markers: creatine kinase (CK), lactate dehydrogenase (LDH), IL-6, TNF-α. Functional measures: maximum muscle strength, perceived pain (VAS), recovery time, performance during repeated efforts.
These results confirm what we observe in practice with our athlete patients: applying photobiomodulation within 30 minutes prior to intensive training constitutes a highly effective preventive strategy against exercise-induced muscle damage.
In scientific practice at Superhuman Wellness, we systematically integrate PBM into recovery protocols for athletes and active individuals with high physical demands. The 37% reduction in CK translates concretely into less destruction of muscle fibers, allowing training sessions to be chained more rapidly and at a higher intensity.
The decrease in IL-6 is particularly significant for patients suffering from low-grade chronic inflammation: PBM plays a systemic anti-inflammatory role, beyond its local effect on the targeted muscle.
We recommend sessions of 15 to 20 minutes at 830 nm, applied to the main muscle groups solicited, at a frequency of 3 times per week for an optimal cumulative effect on training adaptation.